|
1
|
Basile S, Angioli R, Manci N, Palaia I,
Plotti F and Benedetti Panici P: Gynecological cancers in
developing countries: The challenge of chemotherapy in
low-resources setting. Int J Gynecol Cancer. 16:1491–1497. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stewart BW and Kleihues P: World Cancer
Report. IARC Press; Lyon, France: pp. 1–342. 2003
|
|
3
|
Wild CP and Stewart BW: World Cancer
Report 2014. IARC Press; Lyon, France: 2014
|
|
4
|
Kent A: HPV vaccination and testing. Rev
Obstet Gynecol. 3:33–34. 2010.PubMed/NCBI
|
|
5
|
Sylla BS and Wild CP: A million Africans a
year dying from cancer by 2030: What can cancer research and
control offer to the continent? Int J Cancer. 130:245–250. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1. 0, cancer incidence and mortality
worldwideInternational Journal of Cancer. IARC Press; Lyon, France:
2013
|
|
7
|
Jamal S, Mamoon N, Mushtaq S, Luqman M and
Moghal S: The pattern of gynecological malignancies in 968 cases
from Pakistan. Ann Saudi Med. 26:382–384. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aziz Z, Sana S, Saeed S and Akram M:
Institution based tumor registry from Punjab: Five year data based
analysis. J Pak Med Assoc. 53:350–353. 2003.PubMed/NCBI
|
|
9
|
Mishra K: Gynaecological malignancies from
palliative care perspective. Indian J Palliat Care. 17
Suppl:S45–S51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Denny L: Cervical cancer prevention and
treatment in low-resource settingsA textbook of gynecology for
less-resourced locations. First. Sapiens Pub; London: pp. 317–336.
2012
|
|
12
|
Oguntayo O, Zayyan M, Kolawole A, Adewuyi
S, Ismail H and Koledade K: Cancer of the cervix in Zaria, Northern
Nigeria. Ecancermedicalscience. 5:Aug 19–2011.(Epub ahead of
print). PubMed/NCBI
|
|
13
|
Sankaranarayanan R and Ferlay J: Worldwide
burden of gynaecological cancer: The size of the problem. Best
Pract Res Clin Obstet Gynaecol. 20:207–225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nnadi D, Nwobodo E, Airede L, Arkilla M
and Sahabi S: Screening for Cervical Cancer: Experience from a
University Hospital in North Western Nigeria (2007 2009). J Basic
Clin Reprod Sci. 2:18–21. 2013. View Article : Google Scholar
|
|
15
|
Crane K: Palliative care gains ground in
developing countries. J Natl Cancer Inst. Nov 3–2010.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bibi S, Ashfaque S and Laghari NA: A
heartrending burden of gynaecological cancers in advance stage at
nuclear institute of medicine and radiotherapy Jamshoro Sindh. Pak
J Med Sci. 32:120–124. 2016.PubMed/NCBI
|
|
17
|
Nasreen F: Pattern of gynaecological
malignancies in tertiary hospital. JPMI. 16:47–51. 2002.
|
|
18
|
Khan A and Sultana K: Presenting signs and
symptoms of ovarian cancer at a tertiary care hospital. J Pak Med
Assoc. 60:260–262. 2010.PubMed/NCBI
|
|
19
|
Torpy JM, Burke AE and Golub RM: JAMA
patient page. Ovarian cancer. JAMA. 305:2484. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nnadi D, Nwobodo E, Tunau K and Malami S:
Histo-pathological features of primary ovarian tumours managed in a
tertiary hospital, Sokoto. Sahel Med J. 12:171–174. 2009.
|
|
21
|
Galadanci HS, Mohammed AZ, Uzoho CC, Jido
TA and Ochicha O: Gynaecological malignancies seen in a tertiary
health facility in Kano, Northern Nigeria. Trop J Obstet Gynaecol.
20:105–108. 2003.
|
|
22
|
Nnadi D, Singh S, Ahmed Y, Siddique S and
Bilal S: Histo-pathological features of genital tract malignancies
as seen in a tertiary health center in north western Nigeria: A 10
year review. Ann Med Health Sci Res. 4:213–217. 2014. View Article : Google Scholar
|
|
23
|
Coleman MP, Forman D, Bryant H, Butler J,
Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, et al
ICBP Module 1 Working Group, ; Cancer survival in Australia,
Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the
International Cancer Benchmarking Partnership), : An analysis of
population-based cancer registry data. Lancet. 377:127–138. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aniebue UU and Onyeka TC: Ethical,
socioeconomic, and cultural considerations in gynecologic cancer
care in developing countries. Int J Palliat Nurs 2014.
1416272014.doi:10.1155/2014/141627.
|
|
25
|
Raza SA, Franceschi S, Pallardy S, Malik
FR, Avan BI, Zafar A, Ali SH, Pervez S, Serajuddaula S, Snijders
PJ, et al: Human papillomavirus infection in women with and without
cervical cancer in Karachi, Pakistan. Br J Cancer. 102:1657–1660.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yousuf S, Syed S, Moazzam A and Lucky MH:
Frequency of high risk human papilloma virus types in squamous cell
carcinoma of cervix among women. J Pak Med Assoc. 60:193–196.
2010.PubMed/NCBI
|
|
27
|
Gul S, Javed A and Mall S: Awareness about
cervical cancer, human papilloma virus and acceptability of its
vaccine among female university students of Peshawar Pakistan.
Asian J Agri Biol. 3:105–111. 2015.
|
|
28
|
Badar F, Anwar N, Meerza F and Sultan F:
Cervical carcinoma in a Muslim community. Asian Pac J Cancer Prev.
8:24–26. 2007.PubMed/NCBI
|
|
29
|
Khan S, Jaffer NN, Khan MN, Rai MA, Shafiq
M, Ali A, Pervez S, Khan N, Aziz A and Ali SH: Human papilloma
virus subtype 16 is common in Pakistani women with cervical
carcinoma. Int J Infect Dis. 11:313–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aziz N and Yousfani S: Pattern of
presentation of cervical carcinoma at Nuclear Institute of Medicine
and Radiotherapy, Pakistan. Pak J Med Sci. 29:814–817.
2013.PubMed/NCBI
|
|
31
|
Agarwal S, Malhotra KP, Sinha S and
Rajaram S: Profile of gynecologic malignancies reported at a
tertiary care center in India over the past decade: Comparative
evaluation with international data. Indian J Cancer. 49:298–302.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Badar F, Mahmood S, Yusuf MA and Sultan F:
Epidemiology of cancers in Lahore, Pakistan, 2010–2012: A
cross-sectional study. BMJ Open. 6:e0118282016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Okolo CA, Olatokunboh M, Odubanjo M,
Awolude OA and Akang EE: A review of vulvar and vaginal cancers in
Ibadan, Nigeria. NAJMS. 6:76–81. 2013.
|
|
34
|
Nizam K, Haider G, Memon N and Haider A:
Gestational trophoblastic disease: Experience at Nawabshah
Hospital. J Ayub Med Coll Abbottabad. 21:94–97. 2009.PubMed/NCBI
|
|
35
|
Khaskheli M, Khushk IA, Baloch S and Shah
H: Gestational trophoblastic disease: Experience at a tertiary care
hospital of Sindh. J Coll Physicians Surg Pak. 17:81–83.
2007.PubMed/NCBI
|
|
36
|
Rauf B, Hassan L and Ahmed S: Management
of gestational trophoblastic tumours: A five-year clinical
experience. J Coll Physicians Surg Pak. 14:540–544. 2004.PubMed/NCBI
|
|
37
|
Tham BW, Everard JE, Tidy JA, Drew D and
Hancock BW: Gestational trophoblastic disease in the Asian
population of Northern England and North Wales. BJOG. 110:555–559.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Loh KY, Sivalingam N and Suryani MY:
Gestational trophoblastic disease. Med J Malaysia. 59:697–702.
2004.PubMed/NCBI
|
